United Kingdom

The United States spent $1.49 billion on cannabis research between 2000 and 2018. Most of the funds were directed at understanding the potential harms of cannabis use.

United Kingdom Anti-Doping has announced it will shorten bans for athletes who fail drug tests for non-performance enhancing drugs, including cannabis.

Despite legalizing more than 18 months ago, the UK National Health Services has yet to issue a single government-funded prescription for medical cannabis.

Artemis Growth Partners has agreed to the $81 million acquisition of Bridge Farm Group, the UK’s leading ornamental plant, flower, and herb producer.

CBD brand Swissx is reportedly in contact with the Premier League Club team Everton as the firm continues to pursue sponsoring a professional soccer team.

UK officials at the Food Standards Agency say CBD products will be pulled off store shelves next year if they have not received any form of regulatory approval by then.

Epidiolex and Sativex, two cannabinoid-based medicines produced by Britain’s GW Pharmaceuticals, have been formally approved for prescription by the National Institute for Health and Care Excellence (NHS).

About 2.8 percent of British adults claim to self-medicate with cannabis to treat chronic health conditions, according to a recent YouGov poll.

Gibraltar is the latest European jurisdiction to legalize medical cannabis for a variety of conditions, including multiple sclerosis, epilepsy, “life-altering” pain, and side effects from cancer treatment.

Regulators in the UK have banned a $2.56 million ad campaign for Dead Man’s Fingers, a hemp CBD-infused rum product from Cornish Rum Company that leaned on cannabis innuendos in its marketing strategies.

The United Kingdom has given a license to Canada’s Canopy Growth that allows the company to import bulk medical cannabis products into the UK.

The UK’s Imperial College London is partnering with European medical cannabis company EMMAC for a study evaluating cannabis’ entourage effect as a pain relief option.

New survey data suggests that 47 percent of people living in Scotland currently support legalizing cannabis for adult use.

The UK’s National Institute for Health Care and Excellence has decided against recommending CBD products with clobazam for treating treatment-resistant epilepsy conditions, citing CBD’s “unknown” long-term efficacy.

Known British cannabis advocate Blair Gibbs is leaving a position as policy lead for the Centre of Medicinal Cannabis to join the administration of the newly appointed Prime Minister Boris Johnson, whom he has worked for previously.

The latest poll is a five-point increase in favor of legalization compared to a survey conducted last year. According to recent results, just 25 percent of UK voters say they are opposed to legalizing cannabis.